Cyclophosphamide
HPV-Related Anal Squamous Cell Carcinoma
University of Texas Southwestern Medical CenterSmall moleculePhase 2Active
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 81/ 100
Competitive context
10 Active assets in the HPV-Related Anal Squamous Cell Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine Christian Hinrichs | Phase 2 | B |
e7 tcr-t cells Christian Hinrichs | Phase 2 | B |
scg142 SCG Cell Therapy Pte. Ltd. | Phase 1/2 | CC |
Tsc-203-A0201 TScan Therapeutics, Inc. | Phase 1 | CC |
Tsc-200-A0201 TScan Therapeutics, Inc. | Phase 1 | CC |
View all 10 →
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →